These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37235970)

  • 1. Artificial intelligence-quantified tumour-lymphocyte spatial interaction predicts disease-free survival in resected lung adenocarcinoma: A graph-based, multicentre study.
    Feng Z; Lin H; Liu Z; Yan L; Wang Y; Li B; Liu E; Han C; Shi Z; Lu C; Liu Z; Pang C; Li Z; Cui Y; Pan X; Chen X
    Comput Methods Programs Biomed; 2023 Aug; 238():107617. PubMed ID: 37235970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial distance between tumor and lymphocyte can predict the survival of patients with resectable lung adenocarcinoma.
    Pan X; Feng S; Wang Y; Chen J; Lin H; Wang Z; Hou F; Lu C; Chen X; Liu Z; Li Z; Cui Y; Liu Z
    Heliyon; 2024 May; 10(10):e30779. PubMed ID: 38779006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated whole-slide images assessment of immune infiltration in resected non-small-cell lung cancer: towards better risk-stratification.
    Lin H; Pan X; Feng Z; Yan L; Hua J; Liang Y; Han C; Xu Z; Wang Y; Wu L; Cui Y; Huang X; Shi Z; Chen X; Chen X; Zhang Q; Liang C; Zhao K; Li Z; Liu Z
    J Transl Med; 2022 Jun; 20(1):261. PubMed ID: 35672787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
    Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
    J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-scale pathology image texture signature is a prognostic factor for resectable lung adenocarcinoma: a multi-center, retrospective study.
    Wang Y; Pan X; Lin H; Han C; An Y; Qiu B; Feng Z; Huang X; Xu Z; Shi Z; Chen X; Li B; Yan L; Lu C; Li Z; Cui Y; Liu Z; Liu Z
    J Transl Med; 2022 Dec; 20(1):595. PubMed ID: 36517832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of a Methylome-based Malignancy Density Scoring System to predict recurrence risk in early-stage Lung Adenocarcinoma.
    Yang L; Zhang J; Yang G; Xu H; Lin J; Shao L; Li J; Guo C; Du Y; Guo L; Li X; Han-Zhang H; Wang C; Chuai S; Ye J; Kang Q; Liu H; Ying J; Wang Y
    Theranostics; 2020; 10(17):7635-7644. PubMed ID: 32685009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics.
    Choe J; Lee SM; Do KH; Kim S; Choi S; Lee JG; Seo JB
    Eur Radiol; 2020 Sep; 30(9):4952-4963. PubMed ID: 32356158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
    Li B; Cui Y; Diehn M; Li R
    JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of nomogram based on whole tumour size, tumour disappearance ratio on CT and SUVmax on PET in lung adenocarcinoma.
    Song SH; Ahn JH; Lee HY; Lee G; Choi JY; Kang J; Kim EY; Han J; Kwon OJ; Lee KS; Kim HK; Choi YS; Kim J; Shim YM
    Eur Radiol; 2016 Jun; 26(6):1538-46. PubMed ID: 26455720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized tumor-infiltrating lymphocytes density score predicts survival of patients with resectable lung adenocarcinoma.
    Pan X; Lin H; Han C; Feng Z; Wang Y; Lin J; Qiu B; Yan L; Li B; Xu Z; Wang Z; Zhao K; Liu Z; Liang C; Chen X; Li Z; Cui Y; Lu C; Liu Z
    iScience; 2022 Dec; 25(12):105605. PubMed ID: 36505920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma.
    Kim A; Lee SJ; Ahn J; Park WY; Shin DH; Lee CH; Kwon H; Jeong YJ; Ahn HY; I H; Kim YD; Cho JS
    PLoS One; 2019; 14(11):e0224430. PubMed ID: 31743333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated CD163
    Yoshida C; Kadota K; Yamada K; Fujimoto S; Ibuki E; Ishikawa R; Haba R; Yokomise H
    Lung Cancer; 2022 May; 167():34-40. PubMed ID: 35395482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
    Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer.
    Bocchialini G; Lagrasta C; Madeddu D; Mazzaschi G; Marturano D; Sogni F; Silini EM; Gnetti L; Becchi G; Rusca M; Carbognani P; Ventura L; Braggio C; Tiseo M; Quaini F; Ampollini L
    Eur J Cardiothorac Surg; 2020 Sep; 58(3):619-628. PubMed ID: 32267920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma.
    Izar B; Zhou H; Heist RS; Azzoli CG; Muzikansky A; Scribner EE; Bernardo LA; Dias-Santagata D; Iafrate AJ; Lanuti M
    J Thorac Oncol; 2014 Sep; 9(9):1363-9. PubMed ID: 25122432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of tumour-infiltrating lymphocytes and cancer-associated fibroblasts in patients with pancreatic adenocarcinoma of the body and tail undergoing resection.
    Delayre T; Guilbaud T; Resseguier N; Mamessier E; Rubis M; Moutardier V; Fara R; Berdah SV; Garcia S; Birnbaum DJ
    Br J Surg; 2020 May; 107(6):720-733. PubMed ID: 31960955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study.
    Reichling C; Taieb J; Derangere V; Klopfenstein Q; Le Malicot K; Gornet JM; Becheur H; Fein F; Cojocarasu O; Kaminsky MC; Lagasse JP; Luet D; Nguyen S; Etienne PL; Gasmi M; Vanoli A; Perrier H; Puig PL; Emile JF; Lepage C; Ghiringhelli F
    Gut; 2020 Apr; 69(4):681-690. PubMed ID: 31780575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
    Mlecnik B; Van den Eynde M; Bindea G; Church SE; Vasaturo A; Fredriksen T; Lafontaine L; Haicheur N; Marliot F; Debetancourt D; Pairet G; Jouret-Mourin A; Gigot JF; Hubert C; Danse E; Dragean C; Carrasco J; Humblet Y; Valge-Archer V; Berger A; Pagès F; Machiels JP; Galon J
    J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer.
    Zhao K; Li Z; Yao S; Wang Y; Wu X; Xu Z; Wu L; Huang Y; Liang C; Liu Z
    EBioMedicine; 2020 Nov; 61():103054. PubMed ID: 33039706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial intelligence-assisted analysis for tumor-immune interaction within the invasive margin of colorectal cancer.
    Ye Y; Wu X; Wang H; Ye H; Zhao K; Yao S; Liu Z; Zhu Y; Zhang Q; Liang C
    Ann Med; 2023 Dec; 55(1):2215541. PubMed ID: 37224471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.